IBM InfoSphere Information Server 11.3/11.5/11.7 cross-site request forgery
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability was found in IBM InfoSphere Information Server 11.3/11.5/11.7 and classified as problematic. This affects an unknown part. Such manipulation leads to cross-site request forgery. This vulnerability is uniquely identified as CVE-2020-4286. The attack can be launched remotely. No exploit exists.
Details
A vulnerability, which was classified as problematic, has been found in IBM InfoSphere Information Server 11.3/11.5/11.7 (Reporting Software). Affected by this issue is an unknown code. The manipulation with an unknown input leads to a cross-site request forgery vulnerability. Using CWE to declare the problem leads to CWE-352. The web application does not, or can not, sufficiently verify whether a well-formed, valid, consistent request was intentionally provided by the user who submitted the request. Impacted is integrity. CVE summarizes:
IBM InfoSphere Information Server 11.3, 11.5, and 11.7 is vulnerable to cross-site request forgery which could allow an attacker to execute malicious and unauthorized actions transmitted from a user that the website trusts. IBM X-Force ID: 176268.
The weakness was disclosed 05/19/2020 (Website). The advisory is shared for download at exchange.xforce.ibmcloud.com. This vulnerability is handled as CVE-2020-4286 since 12/30/2019. The attack may be launched remotely. No form of authentication is required for exploitation. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 05/20/2020). It is expected to see the exploit prices for this product increasing in the near future.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The entry VDB-155433 is pretty similar. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 4.3
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross-site request forgeryCWE: CWE-352 / CWE-862 / CWE-863
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/30/2019 🔍05/19/2020 🔍
05/20/2020 🔍
10/18/2020 🔍
Sources
Vendor: ibm.comAdvisory: exchange.xforce.ibmcloud.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2020-4286 (🔍)
GCVE (CVE): GCVE-0-2020-4286
GCVE (VulDB): GCVE-100-155432
X-Force: 176268
See also: 🔍
Entry
Created: 05/20/2020 06:23Updated: 10/18/2020 18:29
Changes: 05/20/2020 06:23 (39), 05/20/2020 06:28 (12), 10/18/2020 18:25 (1), 10/18/2020 18:29 (1)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.